Regenxbio (RGNX) Gross Profit Growth (3y) (2017 - 2024)
Regenxbio (RGNX) Gross Profit Growth (3y) (2017 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
411.41% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.16% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Regenxbio |
315.63 Mn |
85.56 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-65.90% |
| Sep 30, 2024 |
-10.85% |
| Jun 30, 2024 |
-1.38% |
| Mar 31, 2024 |
-6.86% |
| Dec 31, 2023 |
-0.64% |
| Sep 30, 2023 |
-41.26% |
| Jun 30, 2023 |
-4.03% |
| Mar 31, 2023 |
1.82% |
| Dec 31, 2022 |
32.51% |
| Sep 30, 2022 |
3.21% |
| Jun 30, 2022 |
49.01% |
| Mar 31, 2022 |
96.64% |
| Dec 31, 2021 |
114.73% |
| Sep 30, 2021 |
51.55% |
| Jun 30, 2021 |
-30.35% |
| Mar 31, 2021 |
-52.38% |
| Dec 31, 2020 |
88.97% |
| Sep 30, 2020 |
399.84% |
| Jun 30, 2020 |
31.34% |
| Mar 31, 2020 |
239.43% |
